You are here:Home
»
Molecular Biology
»
MB-Cancer Markers
»
Carcinoembryonic Antigen, Human, Native, 98+% (CEA, CD66e) (HRP)
Carcinoembryonic Antigen, Human, Native, 98+% (CEA, CD66e) (HRP)
Pricing
For pricing information, USA customers sign in. Outside USA? Please contact your distributor for pricing. Specifications
| Carcinoembryonic antigen (CEA), which is synthesized during development in the fetal gut, and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. | | | Catalog # | C1300-14A | | Applications | Suitable for use in ELISA and antigenic applications in immunological protocols. Other applications not tested. | | Recommended Dilution | Optimal dilutions to be determined by the researcher. | | Storage and Stability | May be stored at 4°C for short-term only. For long-term storage and to avoid repeated freezing and thawing, aliquot. Freeze at -20°C or colder. Aliquots are stable for at least 6 months at -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer. | | Source | Purified human colon carcinoma liver metastases | | Purity | Highly purified ( 98%). No contaminants detected by SDS-PAGE anaylsis and rocket immunoelectrophoresis. Does not crossreact with NCA. | | Concentration | ~1-2mg/ml | | Form | Supplied as a liquid in 20mM Tris, 0.1M sodium chloride. Labeled with horseradish peroxidase (HRP). | | | Important Note | This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications without the expressed written authorization of United States Biological. |
External Links
|
